Latest News by Industry
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported a loss of $1 million in its second quarter.
The South San Francisco, California-based company said it had a loss of 6 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.
The drug developer posted revenue of $36.8 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $32.4 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL